TECH
Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
$51.95
-2.92% today
Updated 2026-04-29
Market cap
$8.13B
P/E ratio
98.02
P/S ratio
6.69x
EPS (TTM)
$0.53
Dividend yield
0.60%
52W range
$46 – $72
Volume
2.2M
Bio-Techne Corp (TECH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$51.95
12-Month target
$11.32
2030 Target
—
Intrinsic (DCF)
$212.04
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.9B | $1.1B | $1.1B | $1.2B | $1.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 6.67%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.